The funding round was co-led by QED Investors and Ventures Platform.

Launched in 2022, Remedial Health aims to revolutionize healthcare access and delivery in Africa by leveraging cutting-edge technology.

The company is on a mission to digitize the pharmaceutical supply chain by providing software for pharmacies and hospitals to manage their inventory and sales.

The startup also helps pharmacies source pharmaceutical products for their shelves from major manufacturers and distributors, including GSK, Pfizer, AstraZeneca, Emzor, and Fidson Healthcare.

The newly secured capital will be used to further expand their platform’s capabilities and scale operations.

Remedial Health’s Series A funding comes during increased interest and investment in Africa’s health tech sector.

With a rapidly growing population and advancements in technology adoption across the continent, investors are recognizing the immense potential for innovative healthcare solutions.

As the healthcare landscape continues to evolve, startups like Remedial Health are at the forefront of driving innovation and leveraging technology to improve lives, making strides towards a healthier and more equitable future for Africa.